Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.

Journal of virology - 9 Nov 2021

Choi Angela, Koch Matthew, Wu Kai, Dixon Groves, Oestreicher Judy, Legault Holly, Stewart-Jones Guillaume B E, Colpitts Tonya, Pajon Rolando, Bennett Hamilton, Carfi Andrea, Edwards Darin K

Abstract excerpt

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has led to growing concerns over increased transmissibility and the ability of some variants to partially escape immunity. Sera from participants immunized on a prime-boost schedule with the mRNA-1273 COVID-19 vaccine were tested for neutralizing activity against several SARS-CoV-2 variants, including variants of concern (VOCs)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Neutralization Tests

Share to Pandemics

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 34549975
DOI: 10.1128/JVI.01313-21
PMCID: PMC8577347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.PMID 34549975Read ↗

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 VariantsSemantic proximity Read ↗

Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary ReportSemantic proximity Read ↗

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceSemantic proximity Read ↗

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceSemantic proximity Read ↗

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernSemantic proximity Read ↗

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsSemantic proximity Read ↗

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited AntibodiesSemantic proximity Read ↗

Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine BoosterSemantic proximity Read ↗

Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 VaccinationSemantic proximity Read ↗

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsSemantic proximity Read ↗

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read ↗

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.